MaxCyte, Inc. (NASDAQ:MXCT) Q3 2024 Earnings Call Transcript
Operator: Hello and welcome to MaxCyte Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Maxcyte Inc. (MXCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 8,188,948 | $31,855,008 | +8% | 1.63% |
| 2. | Millennium Management Israel Englander | 4,192,865 | $16,310,245 | -20% | 0% |
| 3. | Portolan Capital Management George Mccabe | 1,303,438 | $5,070,374 | -23% | 0.36% |
| 4. | Roubaix Capital Christopher Hillary | 427,515 | $1,663,033 | +4% | 0.91% |
| 5. | Royce & Associates Chuck Royce | 323,924 | $1,260,064 | +60% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.90 | 70,443 | 100,000 | 2024-06-10 | Filing | ||
| $4.87 | 29,557 | 29,557 | 2024-06-07 | Filing | ||
| $4.32 | 80,000 | Director | 100,000 | 2023-03-29 | Filing | |
| $11.12 | 20,000 | Director | 20,000 | 2021-11-22 | Filing | |
| $13.00 | 1,800,000 | Large Shareholder | 13,971,334 | 2021-07-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.72 | 47,689 | 269,118 | 2024-11-01 | Filing | ||
| $3.72 | 3,000 | 141,950 | 2024-10-28 | Filing | ||
| $3.71 | 21,607 | 269,118 | 2024-10-02 | Filing | ||
| $3.78 | 26,082 | 269,118 | 2024-10-01 | Filing | ||
| $3.82 | 3,000 | 141,950 | 2024-09-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,341,386 | $34,504,514 | 0% | |
| 2. | 5,282,108 | $24,825,907 | 0% | |
| 3. | 5,043,356 | $23,703,773 | 6.02% | |
| 4. | 3,481,010 | $16,360,746 | 0% | |
| 5. | 2,833,715 | $13,318,460 | 0% |
News See All
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to MaxCyte Second Quarter Earnings Conference Call.
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript
MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc.
Hedge Funds Say These Penny Stocks Are Poised to Explode
Despite common belief, not all penny stocks are inherently risky and suitable only for short-term gains.
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by, and welcome to MaxCyte’s Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to MaxCyte's Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to MaxCyte’s First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by and welcome to MaxCyte's Fourth Quarter Earnings Conference Call. Please be advised that today's conference is being recorded.
Top 5 Stock Picks of Eli Casdin's Casdin Capital
In this article, we discuss the top 5 stock picks of Eli Casdin's Casdin Capital.